Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 1

Research Article

Antibacterial and Anti-Inflammatory Activities of Physalis Alkekengi var. franchetii and Its Main Constituents

Table 1

MIC and MBC of 50-EFP.

Strains 50-EFP (mg/mL)Ceftriaxone sodium (μg/mL)

Staphylococcus aureus ATCC 26112 (MIC)0.8258.00
Staphylococcus aureus ATCC 26112 (MBC)>3.3016.00
Staphylococcus epidermidis ATCC 27342 (MIC)0.8258.00
Staphylococcus epidermidis ATCC 27342 (MBC)6.6016.00
Staphylococcus saprophyticus ATCC 24582 (MIC)1.658.00
Staphylococcus saprophyticus ATCC 24582 (MBC)3.3016.00
Enterococcus faecium ATCC 35667 (MIC)1.654.00
Enterococcus faecium ATCC 35667 (MBC)>6.608.00
Pseudomonas aeruginosa ATCC 27853 (MIC)0.8250.06
Pseudomonas aeruginosa ATCC 27853 (MBC)1.658.00
Streptococcus pneumoniae NCTC 7465 (MIC)0.8250.06
Streptococcus pneumoniae NCTC 7465 (MBC)>13.208.00
Escherichia coli ATCC 87394 (MIC)1.658.00
Escherichia coli ATCC 87394 (MBC)3.3016.00

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.